- 2012 Conference Issue Briefs *New*
- Developing Standards for Breakthrough Therapy Designation
- Design of a Disease-Specific Master Protocol
- Re-evaluating Criteria for Accelerated Approval
- 2012 CCCR Program
- 2011 Conference Overview
- 2011 CCCR Agenda
- Pre-Conference Report – Panel 1: Alternative Trial Designs Based on Tumor Genetics/Pathway Characteristics
- Pre-Conference Report – Panel 2: Evidence for Use of Maintenance Therapy
- Pre-Conference Report – Panel 3: Symptom Measurement in Clinical Trials
- Pre-Conference Report – Panel 4: Development Paths for New Drugs with Large Treatment Effects Seen Early
- 2010 Conference White Paper- Reprinted from Clinical Cancer Research (c)
- 2009 Conference White Paper- Reprinted from The Oncologist (c)
- 2008 Conference White Paper
